세계의 장루 치료 시장 보고서(2025년)

Intestinal Fistula Treatment Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

장루 치료 시장 규모는 향후 몇 년 동안 높은 성장세를 보일 것으로 예상됩니다. 예측 기간의 성장은 원격 의료의 채택 증가, 가처분 소득 증가, 크론병의 유병률 증가, 인구 고령화, 개인 맞춤형 의료에 대한 강조에 기인한 것으로 볼 수 있습니다. 이 기간 동안 예상되는 주요 트렌드에는 AI 기반 진단 도구, 생물학적 제제의 발전, 의료용 3D 프린팅 사용, 통합 치료 모델, 웨어러블 건강 모니터링 디바이스의 채택 등이 있습니다.

위장(GI) 장애의 유병률 증가는 장루 치료 시장의 성장에 크게 기여할 것으로 예상됩니다. 위장 장애는 소화관에 영향을 미치는 광범위한 상태를 포괄하며 통증, 팽만감, 설사 또는 변비와 같은 증상을 유발하며 종종 의학적 개입이 필요합니다. 잘못된 식습관, 스트레스, 정신 건강 문제와 같은 요인이 이러한 질환의 발병률 증가에 기여하고 있습니다. 장루 치료는 비정상적인 장의 연결을 해결하여 이러한 질환을 관리하는 데 필수적입니다. 이 치료는 이러한 연결을 닫고 감염을 예방하며 장 기능을 회복하고 영양실조 및 패혈증과 같은 합병증을 줄이는 데 도움이 됩니다. 예를 들어, 2023년 9월 미국 질병통제예방센터(CDC)에 따르면 미국 성인 약 1,480만 명이 궤양을 앓고 있으며, 매년 3,540만 명이 소화기 질환으로 병원을 방문한다고 합니다. 위장 장애의 유병률이 증가함에 따라 효과적인 장루 치료제에 대한 수요도 그에 따라 증가하고 있습니다.

의료 시설의 개선은 장루 치료 시장의 성장을 이끄는 또 다른 주요 요인입니다. 병원, 클리닉, 진단 센터와 같은 의료 시설은 장루와 같은 질환을 가진 환자를 치료하고 지원하는 데 중요한 역할을 합니다. 이러한 시설은 의료 인프라에 대한 투자 증가, 환자 중심 치료에 대한 관심, 인구 증가, 인구 고령화 등의 요인으로 인해 개선되고 있습니다. 개선된 의료 시설은 장루 치료를 위한 의학적, 외과적, 영양학적 개입을 결합하여 환자의 치료 결과를 개선하는 데 기여합니다. 이는 치료 제공을 최적화하고, 합병증을 줄이고, 입원 기간을 최소화하며, 만성 질환 관리를 개선하는 데 도움이 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 장루 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 장루 치료 시장 : 성장률 분석
• 세계의 장루 치료 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 장루 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 장루 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 장루 치료 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 의약품
• 수술
• 영양 지원
• 기타 치료 유형
• 세계의 장루 치료 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구
• 직장
• 비경구
• 세계의 장루 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 장루 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 외래수술센터(ASC)
• 전문 클리닉
• 기타 최종 사용자
• 세계의 장루 치료 시장 : 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 항생제
• 면역 억제제
• 항분비제
• 통증 관리 약
• 세계의 장루 치료 시장 : 수술 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 누공 폐쇄 수술
• 장절제 수술
• 장루 형성 수술
• 세계의 장루 치료 시장 : 영양 지원 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 비경구 영양
• 경장 영양
• 세계의 장루 치료 시장 : 기타 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 고압 산소 치료
• 내시경 누공 폐쇄술

제7장 지역별 및 국가별 분석

• 세계의 장루 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 장루 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 장루 치료 시장 : 경쟁 구도
• 장루 치료 시장 : 기업 프로파일
  • Merck & Co. KGaA 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bristol-Myers Squibb 개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca plc 개요, 제품 및 서비스, 전략 및 재무 분석
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Medtronic plc 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Medtronic plc
• Eli Lilly and Company
• Moderna Inc.
• Astellas Pharma Inc.
• Boehringer Ingelheim International GmbH
• Cook Group Incorporated
• Integra LifeSciences
• Avante Health Solutions
• Angiplast Pvt. Ltd.
• Angiplast Pvt. Ltd.
• Biolitec AG
• Sklar Surgical Instruments
• Livealth BioPharma
• Surtex Instruments Limited
• Advin Health Care

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 장루 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 장루 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 장루 치료 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Intestinal fistula treatment involves the medical and surgical management of abnormal connections (fistulas) that develop between the intestine and other organs or the skin. Treatment approaches are determined based on the type, location, and severity of the fistula, along with the patient's overall health and the underlying cause of the condition.

The primary treatment options for intestinal fistulas include medications, surgery, nutritional support, and other supportive therapies. Medications are used to manage symptoms and promote healing, administered through various routes such as oral, rectal, and parenteral. These treatments are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized by various end-users, such as hospitals, ambulatory surgical centers, and specialty clinics.

The intestinal fistula treatment market research report is one of a series of new reports from The Business Research Company that provides intestinal fistula treatment market statistics, including the intestinal fistula treatment industry global market size, regional shares, competitors with the intestinal fistula treatment market share, detailed intestinal fistula treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the intestinal fistula treatment industry. This intestinal fistula treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intestinal fistula treatment market size has grown strongly in recent years. It will grow from $25.27 billion in 2024 to $27.10 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increased incidence of gastrointestinal disorders, the rising prevalence of malnutrition, the growing geriatric population, advancements in healthcare infrastructure, and increased healthcare spending.

The intestinal fistula treatment market size is expected to see strong growth in the next few years. It will grow to $35.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing adoption of telemedicine, rising disposable income, the growing prevalence of Crohn's disease, an aging population, and a greater emphasis on personalized medicine. Key trends expected during this period include AI-powered diagnostic tools, advancements in biologics, the use of 3D printing in medical applications, integrated care models, and the adoption of wearable health monitoring devices.

The rising prevalence of gastrointestinal (GI) disorders is expected to significantly contribute to the growth of the intestinal fistula treatment market. GI disorders encompass a wide range of conditions that affect the digestive tract, causing symptoms such as pain, bloating, diarrhea, or constipation, which often require medical intervention. Factors such as poor dietary habits, stress, and mental health issues are contributing to the increasing incidence of these conditions. Intestinal fistula treatment is vital in managing such disorders by addressing abnormal intestinal connections. This treatment helps to close these connections, prevent infections, restore gut function, and reduce complications such as malnutrition and sepsis. For example, according to the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 14.8 million adults in the United States are affected by ulcers, and there are 35.4 million doctor visits annually for digestive issues. As the prevalence of gastrointestinal disorders rises, the demand for effective intestinal fistula treatments grows accordingly.

The improvement in healthcare facilities is another key factor driving the growth of the intestinal fistula treatment market. Healthcare facilities, such as hospitals, clinics, and diagnostic centers, play a crucial role in treating and supporting patients with conditions such as intestinal fistulas. These facilities are improving due to factors such as increased investments in healthcare infrastructure, a focus on patient-centered care, population growth, and aging demographics. Enhanced healthcare facilities contribute to better patient outcomes by offering a combination of medical, surgical, and nutritional interventions for intestinal fistula treatment. This helps optimize care delivery, reduce complications, minimize hospital stays, and improve chronic condition management. For instance, in May 2023, the American Health Care Association reported a 0.591% increase in the number of hospitals in the United States, totaling 6,129 hospitals, which indicates a growing capacity to treat patients, including those requiring intestinal fistula management.

Innovative therapeutic approaches are also playing a pivotal role in advancing the intestinal fistula treatment market. One promising development is mesenchymal stem cell (MSC) therapy, which is being explored for treating refractory perianal fistulas. MSC therapy involves using stem cells to promote tissue healing and regeneration, making it a potential treatment for autoimmune diseases, osteoarthritis, and gastrointestinal disorders. For example, in March 2022, Ossium Health Inc. received an Investigational New Drug (IND) application approval from the U.S. Food and Drug Administration (FDA) for OSSM-001, a mesenchymal stem cell product. This approval enabled the company to proceed with a multi-center Phase 1 clinical trial to assess the safety and feasibility of MSC therapy for fistula healing. The trial is designed to evaluate the safety profile and healing outcomes of this innovative therapy, offering new hope for patients with difficult-to-treat fistulas.

Major players in the intestinal fistula treatment market are Merck & Co. KGaA, Bristol-Myers Squibb, AstraZeneca plc, Pfizer Inc., Medtronic plc, Medtronic plc, Eli Lilly and Company, Moderna Inc., Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Cook Group Incorporated, Integra LifeSciences, Avante Health Solutions, Angiplast Pvt. Ltd., Angiplast Pvt. Ltd., Biolitec AG, Sklar Surgical Instruments, Livealth BioPharma, Surtex Instruments Limited, Advin Health Care.

North America was the largest region in the Intestinal Fistula Treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intestinal fistula treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intestinal fistula treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intestinal fistula treatment market consists of revenues of services of medical management, and supportive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The intestinal fistula treatment market also includes sales of anti-inflammatory drugs, metronidazole, ciprofloxacin and levofloxacin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intestinal Fistula Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intestinal fistula treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intestinal fistula treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intestinal fistula treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medications; Surgery; Nutritional Support; Other Treatment Type
• 2) By Route Of Administration: Oral; Rectal; Parenteral
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-User
• Subsegments:
• 1) By Medications: Antibiotics; Immunosuppressants; Antisecretory Agents; Pain Management Medications
• 2) By Surgery: Fistula Closure Surgery; Bowel Resection Surgery; Stoma Formation Surgery
• 3) By Nutritional Support: Parenteral Nutrition; Enteral Nutrition
• 4) By Other Treatment Type: Hyperbaric Oxygen Therapy; Endoscopic Fistula Closure
• Companies Mentioned: Merck & Co. KGaA; Bristol-Myers Squibb; AstraZeneca plc; Pfizer Inc.; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intestinal Fistula Treatment Market Characteristics

3. Intestinal Fistula Treatment Market Trends And Strategies

4. Intestinal Fistula Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Intestinal Fistula Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intestinal Fistula Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intestinal Fistula Treatment Market Growth Rate Analysis
• 5.4. Global Intestinal Fistula Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intestinal Fistula Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intestinal Fistula Treatment Total Addressable Market (TAM)

6. Intestinal Fistula Treatment Market Segmentation

• 6.1. Global Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery
• Nutritional Support
• Other Treatment Type
• 6.2. Global Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Rectal
• Parenteral
• 6.3. Global Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.4. Global Intestinal Fistula Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Other End-User
• 6.5. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Immunosuppressants
• Antisecretory Agents
• Pain Management Medications
• 6.6. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fistula Closure Surgery
• Bowel Resection Surgery
• Stoma Formation Surgery
• 6.7. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Nutritional Support, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Nutrition
• Enteral Nutrition
• 6.8. Global Intestinal Fistula Treatment Market, Sub-Segmentation Of Other Treatment Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyperbaric Oxygen Therapy
• Endoscopic Fistula Closure

7. Intestinal Fistula Treatment Market Regional And Country Analysis

• 7.1. Global Intestinal Fistula Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intestinal Fistula Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intestinal Fistula Treatment Market

• 8.1. Asia-Pacific Intestinal Fistula Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intestinal Fistula Treatment Market

• 9.1. China Intestinal Fistula Treatment Market Overview
• 9.2. China Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intestinal Fistula Treatment Market

• 10.1. India Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intestinal Fistula Treatment Market

• 11.1. Japan Intestinal Fistula Treatment Market Overview
• 11.2. Japan Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intestinal Fistula Treatment Market

• 12.1. Australia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intestinal Fistula Treatment Market

• 13.1. Indonesia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intestinal Fistula Treatment Market

• 14.1. South Korea Intestinal Fistula Treatment Market Overview
• 14.2. South Korea Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intestinal Fistula Treatment Market

• 15.1. Western Europe Intestinal Fistula Treatment Market Overview
• 15.2. Western Europe Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intestinal Fistula Treatment Market

• 16.1. UK Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intestinal Fistula Treatment Market

• 17.1. Germany Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intestinal Fistula Treatment Market

• 18.1. France Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intestinal Fistula Treatment Market

• 19.1. Italy Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intestinal Fistula Treatment Market

• 20.1. Spain Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intestinal Fistula Treatment Market

• 21.1. Eastern Europe Intestinal Fistula Treatment Market Overview
• 21.2. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intestinal Fistula Treatment Market

• 22.1. Russia Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intestinal Fistula Treatment Market

• 23.1. North America Intestinal Fistula Treatment Market Overview
• 23.2. North America Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intestinal Fistula Treatment Market

• 24.1. USA Intestinal Fistula Treatment Market Overview
• 24.2. USA Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intestinal Fistula Treatment Market

• 25.1. Canada Intestinal Fistula Treatment Market Overview
• 25.2. Canada Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intestinal Fistula Treatment Market

• 26.1. South America Intestinal Fistula Treatment Market Overview
• 26.2. South America Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intestinal Fistula Treatment Market

• 27.1. Brazil Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intestinal Fistula Treatment Market

• 28.1. Middle East Intestinal Fistula Treatment Market Overview
• 28.2. Middle East Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intestinal Fistula Treatment Market

• 29.1. Africa Intestinal Fistula Treatment Market Overview
• 29.2. Africa Intestinal Fistula Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intestinal Fistula Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intestinal Fistula Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intestinal Fistula Treatment Market Competitive Landscape And Company Profiles

• 30.1. Intestinal Fistula Treatment Market Competitive Landscape
• 30.2. Intestinal Fistula Treatment Market Company Profiles
  • 30.2.1. Merck & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Intestinal Fistula Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Eli Lilly and Company
• 31.3. Moderna Inc.
• 31.4. Astellas Pharma Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Cook Group Incorporated
• 31.7. Integra LifeSciences
• 31.8. Avante Health Solutions
• 31.9. Angiplast Pvt. Ltd.
• 31.10. Angiplast Pvt. Ltd.
• 31.11. Biolitec AG
• 31.12. Sklar Surgical Instruments
• 31.13. Livealth BioPharma
• 31.14. Surtex Instruments Limited
• 31.15. Advin Health Care

32. Global Intestinal Fistula Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intestinal Fistula Treatment Market

34. Recent Developments In The Intestinal Fistula Treatment Market

35. Intestinal Fistula Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Intestinal Fistula Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intestinal Fistula Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intestinal Fistula Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료